We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Little Earth Baby is an eco brand offering a range of baby products that are synthetic-free and natural. It aims to become a global market leader in the eco baby space by redesigning synthetic products to develop high-quality alternatives made from plants, not plastic. With the patent-pending designs and a growing loyal customer base, the company is well-placed to serve rising eco-conscious consumer trends. Additionally, Little Earth Baby appeared in the Telegraph's recommendations for Meghan & Harry's royal baby. The company also became a finalist in the Sleeping Bag category at the Australian non-toxic awards. 

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £147,010
PANTSANDSOCKS.COM is an online retailer and subscription service that helps men buy branded underwear and socks. They state their mission is to be a convenient, one-stop-shop for top brands in the market. PANTSANDSOCKS.COM argues that it is an ‘Authorised Stockist’ of 16+ leading brands including Calvin Klein, Hugo Boss, Polo Ralph Lauren and Tommy Hilfiger. The company claims to have fulfilled over 2,000 orders, welcomed over 100,000 unique website visitors to its site, achieved a 4.6/5, ‘Excellent’ Trustpilot rating, and signed up over 4,000 people to its database. The company has integrated with Amazon and Google Shopping to provide additional revenue streams. They state they will use the investment to achieve 100,000 unique visitors per month by the end of Q3 2021, meet its business targets, and continue to develop its internal capabilities at a sustainable rate.

Pitch Rated

64%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £205,504
Try EV is a platform that allows customers to discover, analyze, customize and explore with EVs before making a final buying decision. It encourages “electrify to buy” and intends to change the car purchasing process. The company has also collaborated with big brands such as BMW, Tesla, etc. Try Ev was an Exhibitor at London Motor Show 2019, it was shortlisted for “Greener Greenwich” at Greenwich Business Awards and it was an Elevator Pitch Business Awards finalists at London Motor Show 2018. The funds will be used to balance the growth, to bring key talent, to promote partnerships with major leasing companies and charging networks and to improve marketing and promotion efforts.

Pitch Rated

64%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £88,430
BioScore is a London-based health technology platform that enables you to easily visualize, track, and understand your fitness and health test results. It is currently designed as a software service for health and fitness professionals, gyms, personal trainers, sports coaches, sports clubs, schools, other allied health consultants and their clients. Leveraging on the trend of health optimization, BioScore aims to provide meaningful infographics and explanations, linked test histories, and personalised advice and action plans from fitness or health experts to their respective end-users, resulting in more effective diagnosis of ailments. The company will utilise the investment to develop an athlete management platform with an inspiring infographic, reporting and sell licences to access the platform's suite of online tools.

Pitch Rated

63%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £57,580
GIBIE combines ancient Indian dying methods with modern weaving technologies to produce sustainable and luxurious homewares. The company argues that the textile industry uses an astonishing 9 trillion gallons of water annually, as well as, releases harmful gases and chemicals in the air and water. GIBIE aims to change this scenario by bringing forth sustainable linen that has superior qualities to chemically enhanced and dyed linen. It has come out with an industrial-scale production proposal of its linen. The company is a PETA-approved vegan brand and a member of the Color Ashram Foundation that promotes the usage of herbal dyes around the world. GIBIE will use the investment to launch its essential sales programs, boost marketing initiatives and scale production.

Pitch Rated

57%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £158,571
WELD is a fitness company on a mission to make on-demand health, fitness and wellbeing available to all ages & abilities. The company allows users and instructors to set the time and place for the training session, rent out their home or commercial spaces for activities, or interact 1-2-1 online. This approach, the company believes, helps personal trainers, hit by the Covid-19 lockdown, find clients. WELD also allows trainers to set their prices and keep 90% of their fees, and lets customers enjoy a 2% commission on referrals for every future session taken in perpetuity. WELD aims to tap into the $94 billion global fitness and wellness market that grew 8.7% from 2018/19. The company's primary target audience is Generation Z that, the company believes, embraced wellness. WELD will use the investment to improve its platform, boost marketing and plug the fitness & wellness gap. 

Pitch Rated

56%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £199,227
Nooro makes cannabidiol (CBD) snack bars. Company founder J.D. Furlong asserts that blending CBD and certain nootropics lead to better cognitive functions in individuals. Nooro also argues that it is the UK's first CBD snack bar seller that is plant-based and gluten-free. The company's products are stocked across 250 retail outlets, cafes, gyms, and delis across the UK. Nooro pivoted to Direct-to-Consumer (D2C) sales during COVID-19 to get better margins. It invested in creating a business model with four distinct revenue streams with 60% earnings coming via e-commerce D2C sales, 15% via digital affiliate sales, 15% via direct sales to partners, and 10% via wholesalers. The company will use the investment to launch an additional three new flavours by February 2021 and grow its business across different verticals.

Pitch Rated

56%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £235,819
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £270,543
Bua Fit is easy to use, a simple way to book web application for outdoor fitness classes. It eliminates all the trouble by connecting the trainers to clients for group fitness classes and gives the customers a diversity of trainers. The company has been a finalist in The Great British Entrepreneurial Challenge, has a network of 100 trainers and 42% active user rate since launch. With the proceeds, the company will earn more users, more trainers, more revenue, invest in product development and expand the team.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £205,378
Her.9 is a Direct-To-Consumer (DTC) female technology brand that caters to the needs of women during pregnancy. It cites research arguing that up to 40% of women taking prenatal vitamins may not be able to absorb the folic acid within the UK’s leading pregnancy brand. Her.9 aims to resolve this by employing DUOCAP technology. The company asserts that DUOCAP is a capsule-in-capsule delivery system which contains solubilised prebiotics in the outer capsule and probiotics in the inner capsule. The prebiotic releases immediately and the probiotic releases later allowing for targeted supplement delivery in the body. The prenatal supplements market is set to be worth $56 billion globally by 2024. Her.9 aims to be a notable contender in this segment. The company is raising investment to build its already established partnerships and execute its marketing strategy effectively.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £215,946
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph